190 related articles for article (PubMed ID: 24567233)
21. [Is micafungin useful in the prophylaxis of invasive fungal disease in hematological patients?].
Salavert M; Jarque I
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():43-9. PubMed ID: 21420577
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of prophylactic micafungin in very-low-birth-weight infants.
Kawada M; Fukuoka N; Kondo M; Okazaki K; Kusaka T; Kawada K; Itoh S
Pediatr Infect Dis J; 2009 Sep; 28(9):840-2. PubMed ID: 19636279
[TBL] [Abstract][Full Text] [Related]
23. Effect of liver and kidney function on migafungin disposition in patients with hematologic malignancies.
Nakagawa Y; Ichii Y; Saeki Y; Kodama M; Kishino S; Suzuki K
Eur J Drug Metab Pharmacokinet; 2008; 33(3):191-8. PubMed ID: 19007046
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of micafungin versus extensive azoles in the prevention and treatment of invasive fungal infections for neutropenia patients with hematological malignancies: A meta-analysis of randomized controlled trials.
Lee CH; Lin JC; Ho CL; Sun M; Yen WT; Lin C
PLoS One; 2017; 12(7):e0180050. PubMed ID: 28700646
[TBL] [Abstract][Full Text] [Related]
25. The impact of total bilirubin on plasma micafungin levels in living-donor liver transplantation recipients with severe liver dysfunction.
Muraki Y; Iwamoto T; Kagawa Y; Sakurai H; Usui M; Isaji S; Uemoto S; Okuda M
Biol Pharm Bull; 2009 Apr; 32(4):750-4. PubMed ID: 19336919
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haplo-identical hematopoietic SCT.
El-Cheikh J; Venton G; Crocchiolo R; Fürst S; Faucher C; Granata A; Oudin C; Coso D; Bouabdallah R; Vey N; Duran S; Fougereau E; Berger P; Chabannon C; Blaise D
Bone Marrow Transplant; 2013 Nov; 48(11):1472-7. PubMed ID: 23749104
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea.
Sohn HS; Lee TJ; Kim J; Kim D
Clin Ther; 2009 May; 31(5):1105-15; discussion 1066-8. PubMed ID: 19539111
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of micafungin for the prophylaxis of invasive fungal infection during neutropenia in children and adolescents undergoing allogeneic hematopoietic SCT.
Park HJ; Park M; Han M; Nam BH; Koh KN; Im HJ; Lee JW; Chung NG; Cho B; Kim HK; Yoo KH; Koo HH; Kang HJ; Shin HY; Ahn HS; Lim YT; Kook H; Lyu CJ; Hah JO; Park JE; Lim YJ; Seo JJ
Bone Marrow Transplant; 2014 Sep; 49(9):1212-6. PubMed ID: 25000455
[TBL] [Abstract][Full Text] [Related]
29. Safety and pharmacokinetic profiles of repeated-dose micafungin in children and adolescents treated for invasive candidiasis.
Benjamin DK; Deville JG; Azie N; Kovanda L; Roy M; Wu C; Arrieta A
Pediatr Infect Dis J; 2013 Nov; 32(11):e419-25. PubMed ID: 23958810
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.
Kubiak DW; Bryar JM; McDonnell AM; Delgado-Flores JO; Mui E; Baden LR; Marty FM
Clin Ther; 2010 Apr; 32(4):637-48. PubMed ID: 20435233
[TBL] [Abstract][Full Text] [Related]
31. Safety of micafungin in pediatric clinical trials.
Arrieta AC; Maddison P; Groll AH
Pediatr Infect Dis J; 2011 Jun; 30(6):e97-e102. PubMed ID: 21378595
[TBL] [Abstract][Full Text] [Related]
32. Comparison of long-term and short-term administration of itraconazole for primary antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell transplantation: a multicenter, randomized, open-label trial.
Lin R; Xu X; Li Y; Sun J; Fan Z; Jiang Q; Huang F; Zhou H; Nie D; Guo Z; Mao Y; Xiao Y; Liu Q
Transpl Infect Dis; 2014 Apr; 16(2):286-94. PubMed ID: 24593273
[TBL] [Abstract][Full Text] [Related]
33. Echinocandin prophylaxis in patients undergoing haematopoietic cell transplantation and other treatments for haematological malignancies.
Epstein DJ; Seo SK; Brown JM; Papanicolaou GA
J Antimicrob Chemother; 2018 Jan; 73(suppl_1):i60-i72. PubMed ID: 29304213
[TBL] [Abstract][Full Text] [Related]
34. Antifungal prophylaxis with micafungin in patients treated for childhood cancer.
Kusuki S; Hashii Y; Yoshida H; Takizawa S; Sato E; Tokimasa S; Ohta H; Ozono K
Pediatr Blood Cancer; 2009 Oct; 53(4):605-9. PubMed ID: 19533659
[TBL] [Abstract][Full Text] [Related]
35. Micafungin use in children.
Emiroglu M
Expert Rev Anti Infect Ther; 2011 Sep; 9(9):821-34. PubMed ID: 21905789
[TBL] [Abstract][Full Text] [Related]
36. Micafungin as antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell transplantation: results of different dosage levels in clinical practice.
Langebrake C; Rohde H; Lellek H; Wolschke C; Kröger NM
Clin Transplant; 2014 Mar; 28(3):286-91. PubMed ID: 24479680
[TBL] [Abstract][Full Text] [Related]
37. Posaconazole prophylaxis in neutropenic patients with hematological malignancies: limits in clinical practice.
Bourdelin M; Grenouillet F; Daguindau E; Muret P; Desbrosses Y; Dubut J; Deconinck E; Limat S; Larosa F
Med Mycol; 2014 Oct; 52(7):728-35. PubMed ID: 25012993
[TBL] [Abstract][Full Text] [Related]
38. Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseases.
Cornely OA; Pappas PG; Young JA; Maddison P; Ullmann AJ
Expert Opin Drug Saf; 2011 Mar; 10(2):171-83. PubMed ID: 21306282
[TBL] [Abstract][Full Text] [Related]
39. A cost and resource utilization analysis of micafungin bridging for hemato-oncological high-risk patients undergoing allogeneic stem cell transplantation.
Heimann SM; Vehreschild MJ; Cornely OA; Franke B; von Bergwelt-Baildon M; Wisplinghoff H; Kron F; Scheid C; Vehreschild JJ
Eur J Haematol; 2015 Jun; 94(6):526-31. PubMed ID: 25310918
[TBL] [Abstract][Full Text] [Related]
40. [Differential pharmacokinetic characteristics of micafungin. Experience in special populations].
Grau Cerrato S; Luque Pardos S; Ferrández Quirante O
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():10-4. PubMed ID: 21420571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
